Optimizing Pharmacist Impact in Critically Ill Patients: Is Medication Regimen Complexity the Answer?
- PMID: 35984054
- DOI: 10.1097/CCM.0000000000005603
Optimizing Pharmacist Impact in Critically Ill Patients: Is Medication Regimen Complexity the Answer?
Conflict of interest statement
Dr. Miano has disclosed that he does not have any potential conflicts of interest.
Comment on
-
Impact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics With the Medication Regimen Complexity-ICU (MRC-ICU) Score.Crit Care Med. 2022 Sep 1;50(9):1318-1328. doi: 10.1097/CCM.0000000000005585. Epub 2022 Aug 15. Crit Care Med. 2022. PMID: 35678204 Free PMC article.
References
-
- Leape LL, Cullen DJ, Clapp MD, et al.: Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282:267–270
-
- MacLaren R, Bond CA, Martin SJ, et al.: Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med 2008; 36:3184–3189
-
- Zampieri FG, Salluh JIF, Azevedo LCP, et al.; ORCHESTRA Study Investigators: ICU staffing feature phenotypes and their relationship with patients’ outcomes: An unsupervised machine learning analysis. Intensive Care Med 2019; 45:1599–1607
-
- Lee H, Ryu K, Sohn Y, et al.: Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams: A systematic review and meta-analysis. Crit Care Med 2019; 47:1243–1250
-
- Erstad BL: Justification of the value of critical care pharmacists: Still a work in progress? Am J Health Syst Pharm 2020; 77:1906–1909
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
